Last reviewed · How we verify

Placebo-Oral

Eli Lilly and Company · FDA-approved active Small molecule Quality 5/100

Placebo-Oral is a Small molecule drug developed by Eli Lilly and Company. It is currently FDA-approved for Clinical trial control comparator (not a therapeutic indication). Also known as: Placebo, XP19986 matching placebo, Uralyt-U, Placebo (aluminum hydroxide).

Placebo produces no pharmacological effect and works entirely through the placebo effect, a psychobiological response to the expectation of treatment.

Placebo produces no pharmacological effect and works entirely through the placebo effect, a psychobiological response to the expectation of treatment. Used for Clinical trial control comparator (not a therapeutic indication).

At a glance

Generic namePlacebo-Oral
Also known asPlacebo, XP19986 matching placebo, Uralyt-U, Placebo (aluminum hydroxide)
SponsorEli Lilly and Company
ModalitySmall molecule
PhaseFDA-approved

Mechanism of action

Placebo is an inert substance that contains no active pharmaceutical ingredient. Its therapeutic effects, when observed, arise from the patient's psychological expectation of benefit, activation of endogenous healing mechanisms, and contextual factors in the clinical setting rather than from direct molecular action. Placebo is used as a control comparator in clinical trials to distinguish true drug efficacy from placebo response.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Placebo-Oral

What is Placebo-Oral?

Placebo-Oral is a Small molecule drug developed by Eli Lilly and Company, indicated for Clinical trial control comparator (not a therapeutic indication).

How does Placebo-Oral work?

Placebo produces no pharmacological effect and works entirely through the placebo effect, a psychobiological response to the expectation of treatment.

What is Placebo-Oral used for?

Placebo-Oral is indicated for Clinical trial control comparator (not a therapeutic indication).

Who makes Placebo-Oral?

Placebo-Oral is developed and marketed by Eli Lilly and Company (see full Eli Lilly and Company pipeline at /company/eli-lilly).

Is Placebo-Oral also known as anything else?

Placebo-Oral is also known as Placebo, XP19986 matching placebo, Uralyt-U, Placebo (aluminum hydroxide).

What development phase is Placebo-Oral in?

Placebo-Oral is FDA-approved (marketed).

What are the side effects of Placebo-Oral?

Common side effects of Placebo-Oral include Nocebo effects (adverse events attributed to placebo expectation).

Related